Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents
- PMID: 12824780
- DOI: 10.1097/00002030-200307040-00003
Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents
Abstract
Background: HIV-infected adults with lipodystrophy, characterized by excess accumulation of intra-abdominal adipose tissue (IAT), showed impaired growth hormone (GH) secretion. Data are lacking in paediatric lipodystrophy with the same features.
Methods: Twenty-five pubertal HIV-infected children were assessed for GH response (GH-AUC(0-120 min)) to arginine + GHRH testing, insulin-like growth factor-1 (IGF-1), IGF binding protein 3 (IGFBP-3), insulin, glucose, cholesterol, triglycerides, free fatty acids and nitric oxide levels. Body composition and IAT content were evaluated by dual-energy x-ray-absorptiometry and magnetic resonance imaging. An excess accumulation of IAT was defined as a value > 41 cm2. Differences between children with (V+) and without (V-) excess IAT were assessed by non-parametric tests and multivariate analysis. RESULTS Ten V+ (mean IAT, 82.5 cm2) and 15 V- (mean IAT, 26.8 cm2) were identified; they were similar for age (13.8 versus 14.8 years), body mass index (20.2 versus 19.5 kg/m2), male : female ratio (3/7 versus 8/7), months on highly active antiretroviral therapy (54.5 versus 55 months). V+ showed lower GH-AUC(0-120 min) (16.4 versus 31.6 microg x h/l; P = 0.002), lower IGF-1 concentrations (384 versus 515 ng/ml; P = 0.03) and higher insulin levels (17.8 versus 10.5 microIU/ml; P = 0.01) than V-. V+, as compared to V-, showed lower lean mass (total, P = 0.025; arms, P = 0.024; legs, P = 0.008) and higher fat mass (total, P = 0.0038; arms, P = 0.028; trunk, P < 0.0001). Lipid profile and glucose, IGFBP-3, nitric oxide and free fatty acids levels were similar in the two groups. GH-AUC(0-120 min) correlated negatively with IAT content and insulin levels.
Conclusion: Impaired GH secretion is detectable in pubertal children with increased visceral adiposity and hyperinsulinemia. GH therapy should be considered in lipodystrophic HIV-infected children with excess IAT.
Similar articles
-
Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents.J Clin Endocrinol Metab. 2005 Jul;90(7):4075-80. doi: 10.1210/jc.2004-2431. Epub 2005 Apr 19. J Clin Endocrinol Metab. 2005. PMID: 15840750
-
Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.JAMA. 2004 Jul 14;292(2):210-8. doi: 10.1001/jama.292.2.210. JAMA. 2004. PMID: 15249570 Clinical Trial.
-
Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy.Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E296-303. doi: 10.1152/ajpendo.00335.2003. Epub 2003 Oct 14. Am J Physiol Endocrinol Metab. 2004. PMID: 14559725 Clinical Trial.
-
Growth hormone deficiency and human immunodeficiency virus.Best Pract Res Clin Endocrinol Metab. 2017 Feb;31(1):91-111. doi: 10.1016/j.beem.2017.02.006. Epub 2017 Feb 24. Best Pract Res Clin Endocrinol Metab. 2017. PMID: 28477736 Review.
-
Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV/AIDS.Rev Endocr Metab Disord. 2013 Jun;14(2):113-8. doi: 10.1007/s11154-013-9245-9. Rev Endocr Metab Disord. 2013. PMID: 23657561 Review.
Cited by
-
Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.Paediatr Drugs. 2010 Jun;12(3):187-99. doi: 10.2165/11532520-000000000-00000. Paediatr Drugs. 2010. PMID: 20481647 Review.
-
Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.AIDS. 2009 Mar 27;23(6):661-72. doi: 10.1097/QAD.0b013e3283269dfb. AIDS. 2009. PMID: 19279441 Free PMC article.
-
Low-dose growth hormone for 40 weeks induces HIV-1-specific T cell responses in patients on effective combination anti-retroviral therapy.Clin Exp Immunol. 2013 Sep;173(3):444-53. doi: 10.1111/cei.12141. Clin Exp Immunol. 2013. PMID: 23701177 Free PMC article. Clinical Trial.
-
Growth and the pubertal growth spurt in South African adolescents living with perinatally-acquired HIV infection.PLoS One. 2022 Jan 25;17(1):e0262816. doi: 10.1371/journal.pone.0262816. eCollection 2022. PLoS One. 2022. PMID: 35077489 Free PMC article.
-
Delay in sexual maturation in perinatally HIV-infected youths is mediated by poor growth.AIDS. 2017 Jun 1;31(9):1333-1341. doi: 10.1097/QAD.0000000000001486. AIDS. 2017. PMID: 28358737 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous